EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Biomarkers for Predicting Malignant Transformation of Premalignant Lesions of the Larynx: A Systematic Review

Juan P Rodrigo iD, Reydson Alcides de Lima-Souza iD, Fernando López, Göran Stenman iD, Abbas Agaymy, Miquel Quer iD, Vinidh Paleri iD, Ilmo Leivo, Alfons Nadal iD, Nina Zidar iD, Fernanda V Mariano, Henrik Hellquist iD und 2 weitere

Diagnostics · 12.01.2026 · 16 (2) · 236

DOI: 10.3390/diagnostics16020236 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 12.01.2026. Verfasst von Juan P Rodrigo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Hospital Universitario Central de Asturias, University of Oviedo, Instituto de Investigación Sanitaria del Principado d…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Premalignant laryngeal lesions carry a variable risk of malignant transformation to squamous cell carcinoma. Identifying reliable biomarkers that predict malignant transformation could improve patient management and surveillance strategies. The objective of this work is to perform a systematic review of the literature on biomarkers that predict malignant transformation of premalignant laryngeal lesions.

Methods

We conducted a systematic review following PRISMA 2020 guidelines. The PubMed, Scopus and Embase databases, and Google Scholar were searched for studies published between January 2011 and November 2025. Studies investigating biomarkers that predict malignant transformation of histopathologically confirmed premalignant laryngeal lesions were included. Risk of bias was assessed using the ROBINS-I tool.

Results

From 166 initially identified records, 11 studies met the inclusion criteria, including 730 patients. These studies investigated diverse biomarker categories such as protein markers (cortactin, FAK, NANOG, SOX2, CSPG4), immune markers (tumor-infiltrating lymphocytes, immune gene signatures), microRNAs (miR-183-5p, miR-155-5p, miR-106b-3p), and genetic markers (chromosomal instability, PIK3CA amplification and mutations, FGFR3 mutations). Five studies provided adequate follow-up data on transformation outcomes. Most studies showed a moderate to serious risk of bias primarily due to limited confounder control and incomplete reporting.

Conclusions

While several promising biomarker candidates have been identified, the evidence base remains limited due to small sample sizes, heterogeneous methodologies, and inadequate follow-up data. Cortactin/FAK protein expression and immune signatures are the most promising but require validation in larger, well-designed prospective cohorts.

Schlagwörter

Stichwörter der Autor:innen

ROBINS-Ibiomarkerslaryngeal dysplasiamalignant transformationpremalignant lesionssystematic review

Autor:innen und Institutionen

  • Department of Otolaryngology, Hospital Universitario Central de Asturias, University of Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias, Instituto Universitario de Oncología del Principado de Ast…
  • CIBER de Cáncer (CIBERONC), 28029 Madrid, Spain.
  • Department of Oral Diagnosis, Faculdade de Odontologia de Piracicaba, Universidade Estadual de Campinas (UNICAMP), Piracicaba 13414-903, SP, Brazil.
  • Department of Pathology, Sahlgrenska Center for Cancer Research, Sahlgrenska University Hospital, University of Gothenburg, 405 30 Gothenburg, Sweden.
  • Institute of Pathology, University Hospital Erlangen, 91054 Erlangen, Germany.
  • Department of Otolaryngology, Hospital Santa Creu y Sant Pau, 08041 Barcelona, Spain.

ORCID-Profile: Juan P Rodrigo, Reydson Alcides de Lima-Souza, Göran Stenman, Miquel Quer, Vinidh Paleri, Alfons Nadal, Nina Zidar, Henrik Hellquist, Alfio Ferlito

Zitieren

APA

Rodrigo, J. P., de Lima-Souza, R. A., López, F., Stenman, G., Agaymy, A., Quer, M., Paleri, V., Leivo, I., Nadal, A., Zidar, N., Mariano, F. V., Hellquist, H., Gale, N., & Ferlito, A. (2026). Biomarkers for Predicting Malignant Transformation of Premalignant Lesions of the Larynx: A Systematic Review. Diagnostics, 16(2), 236. https://doi.org/10.3390/diagnostics16020236

Vancouver

Rodrigo JP, de Lima-Souza RA, López F, Stenman G, Agaymy A, Quer M, et al. Biomarkers for Predicting Malignant Transformation of Premalignant Lesions of the Larynx: A Systematic Review. Diagnostics. 2026;16(2):236. doi:10.3390/diagnostics16020236

BibTeX
@article{Rodrigo2026,
  author = {Rodrigo, Juan P and de Lima-Souza, Reydson Alcides and López, Fernando and Stenman, Göran and Agaymy, Abbas and Quer, Miquel and Paleri, Vinidh and Leivo, Ilmo and Nadal, Alfons and Zidar, Nina and Mariano, Fernanda V and Hellquist, Henrik and Gale, Nina and Ferlito, Alfio},
  title = {Biomarkers for Predicting Malignant Transformation of Premalignant Lesions of the Larynx: A Systematic Review},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {236},
  doi = {10.3390/diagnostics16020236}
}
Kostenlos starten →